Patient quality of life (QoL)

Patient quality of life (QoL) maintained after 1st-line chemotherapy: comparable effect of VARGATEF® + docetaxel on self-reported global health status/QoL to placebo + docetaxel (HR: 0.86; 95% CI: 0.71-1.05) in adenocarcinoma patients1


Differences in mean score for cough, dyspnea and pain1

Data Table: Difference in mean score

HR = hazard ratio
95% CI = 95% confidence interval
QoL = quality of life
NS = not significant



References

1
Novello S et al. Eur J Cancer 2015; 51:317– 326.